Walter Ageno to Aged, 80 and over
This is a "connection" page, showing publications Walter Ageno has written about Aged, 80 and over.
Connection Strength
0.119
-
Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency. Thromb Res. 2020 12; 196:209-212.
Score: 0.025
-
Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study. Vasc Med. 2017 12; 22(6):518-524.
Score: 0.020
-
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb Haemost. 2017 04 03; 117(4):794-800.
Score: 0.020
-
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
Score: 0.007
-
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med. 2021 Jun; 16(4):1005-1015.
Score: 0.007
-
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
Score: 0.006
-
Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study. Thromb Res. 2019 Nov; 183:28-32.
Score: 0.006
-
Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly. Thromb Res. 2019 02; 174:148-150.
Score: 0.006
-
Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry. Intern Emerg Med. 2018 Oct; 13(7):1051-1058.
Score: 0.005
-
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial. Thromb Res. 2018 02; 162:7-14.
Score: 0.005
-
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study. Thromb Res. 2017 Aug; 156:155-159.
Score: 0.005
-
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. Thromb Res. 2017 May; 153:97-100.
Score: 0.005
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008 Jun 26; 358(26):2776-86.
Score: 0.003